Researchers found that mobile units with peer navigation improved health outcomes for participants with opioid use disorder, with about seven percent on medication and 35 percent virally suppressed. The study also showed lower odds of all-cause mortality in the intervention arm.
The COVID-19 Prevention Network is launching two Phase 3 trials to evaluate the effectiveness of LY-CoV555 and REGN-COV-2 monoclonal antibodies in preventing SARS-CoV-2 infection among high-risk groups. These trials aim to explore the potential of mAbs as a rapid solution to prevent COVID-19 acquisition.
Mathematical modelling and cost-effectiveness analyses project substantial reductions in new HIV cases with sustained community-wide testing and prompt treatment. The HPTN 071 study found a sustained intervention to be cost-effective, reducing costs per disability-adjusted life-year.
A new study by the HIV Prevention Trials Network found that financial incentives had no significant overall impact on achieving viral suppression among HIV-positive patients. However, specific clinical settings such as hospital-based clinics and those with lower patient engagement saw enhanced viral suppression rates. The study also sh...
HIV Prevention Trials Network (HPTN) has initiated two phase 2 studies to evaluate the safety and acceptability of long-acting injectable antiretroviral drugs, a promising advancement in HIV prevention. The studies aim to provide an alternative to daily oral PrEP pills, which have shown limitations in some trials.
The study demonstrates that community efforts can significantly increase HIV testing rates, especially among men and young individuals. The intervention communities showed a 45% higher rate of testing for men compared to control communities, leading to a 14% reduction in new HIV infections.
A new analysis of the HPTN 052 study results shows that early antiretroviral therapy (ART) is a triple winner: improving patient health, protecting partners, and being very cost-effective. The strategy can increase survival, prevent costly opportunistic infections, and avert early transmissions.
The HPTN 052 study found that early antiretroviral therapy significantly delayed the time to both AIDS and non-AIDS primary events and reduced the overall incidence of clinical events. Immediate ART also decreased the incidence of clinical events likely due to reversal of immune suppression.
A recent HPTN study found significantly higher rates of new HIV infections among young black gay and bisexual men in the US compared to white MSM. The study's findings highlight the need for urgent action to stem the spread of HIV among this population.
A new study reveals that HIV incidence rate for US black women is five times higher than the overall estimated rate for black adolescent and adult women. The study found an HIV incidence of 0.24% among 2,099 women, comparable to rates in sub-Saharan Africa.